Expert Review of Anticancer Therapy, Volume 21, Issue 11 (2021)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Review of Anticancer Therapy, Volume 21, Issue 11 (2021)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Volume 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Editorial

Editorial
How can we create precision immunotherapy as standard in breast cancer?
Zachary C. Hartman
Pages: 1179-1181
Published online: 05 Jul 2021
First Page PreviewforHow can we create precision immunotherapy as standard in breast cancer? | Full Text | References | PDF (138.4 KB) | EPUB
  • 1395 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Drug Profile

Article
Cabozantinib and nivolumab as first-line treatment in advanced renal cell carcinoma
Maria Giuseppa Vitale, Cecilia Nasso, Marco Oltrecolli, Cinzia Baldessari, Martina Fanelli, Massimo Dominici & Roberto Sabbatini
Pages: 1183-1192
Published online: 27 Aug 2021
AbstractforCabozantinib and nivolumab as first-line treatment in advanced renal cell carcinoma | Full Text | References | PDF (338.3 KB) | EPUB
  • 400 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Trastuzumab deruxtecan and other HER2-targeting agents for the treatment of HER2-positive gastric cancer
Takahiro Ishii & Kohei Shitara
Pages: 1193-1201
Published online: 29 Sep 2021
AbstractforTrastuzumab deruxtecan and other HER2-targeting agents for the treatment of HER2-positive gastric cancer | Full Text | References | PDF (329.8 KB) | EPUB
  • 629 Views
  • 4 CrossRef citations
  • 0Altmetric

Meeting report

2021 ASCO genitourinary cancers symposium: a focus on renal cell carcinoma
Roberto Iacovelli, Maria Antonella Cannella, Chiara Ciccarese, Serena Astore, Nazario Foschi, Giuseppe Palermo & Giampaolo Tortora
Pages: 1203-1206
Published online: 09 Sep 2021
Abstractfor2021 ASCO genitourinary cancers symposium: a focus on renal cell carcinoma | Full Text | References | PDF (172.7 KB) | EPUB
  • 373 Views
  • 0 CrossRef citations
  • 0Altmetric
Inside prostate cancer news from the 2021 ASCO Genitourinary Cancers Symposium
Roberto Iacovelli, Serena Astore, Chiara Ciccarese, Maria Antonella Cannella, Pierluigi Bove, Valerio Iacovelli & Giampaolo Tortora
Pages: 1207-1210
Published online: 09 Sep 2021
AbstractforInside prostate cancer news from the 2021 ASCO Genitourinary Cancers Symposium | Full Text | References | PDF (171.9 KB) | EPUB
  • 241 Views
  • 1 CrossRef citations
  • 0Altmetric

Review

Immune checkpoint inhibitors and cardiotoxicity: possible mechanisms, manifestations, diagnosis and management
Seyed Parsa Eftekhar, Niloufar Yazdanpanah & Nima Rezaei
Pages: 1211-1228
Published online: 21 Sep 2021
AbstractforImmune checkpoint inhibitors and cardiotoxicity: possible mechanisms, manifestations, diagnosis and management | Full Text | References | PDF (5.8 MB) | EPUB
  • 395 Views
  • 1 CrossRef citations
  • 0Altmetric
Adjuvant therapy in non-small cell lung cancer: is targeted therapy joining the standard of care?
Carolina Gabay, Alessandro Russo, Luis E. Raez & Christian Rolfo Cervetto
Pages: 1229-1235
Published online: 25 Sep 2021
AbstractforAdjuvant therapy in non-small cell lung cancer: is targeted therapy joining the standard of care? | Full Text | References | PDF (996.2 KB) | EPUB
  • 234 Views
  • 4 CrossRef citations
  • 0Altmetric
Combined endocrine and targeted therapy in luminal breast cancer
Marcelle Goldner, Natasha Pandolfi, Debora Maciel, Julianne Lima, Solange Sanches & Noam Pondé
Pages: 1237-1251
Published online: 07 Sep 2021
AbstractforCombined endocrine and targeted therapy in luminal breast cancer | Full Text | References | PDF (1.8 MB) | EPUB
  • 663 Views
  • 3 CrossRef citations
  • 0Altmetric
Molecular-driven treatment for biliary tract cancer: the promising turning point
Mara Persano, Marco Puzzoni, Pina Ziranu, Valeria Pusceddu, Eleonora Lai, Andrea Pretta, Clelia Donisi, Giovanna Pinna, Dario Spanu, Erika Cimbro, Alissa Parrino, Nicole Liscia, Stefano Mariani, Marco Dubois, Marco Migliari & Mario Scartozzi
Pages: 1253-1264
Published online: 24 Sep 2021
AbstractforMolecular-driven treatment for biliary tract cancer: the promising turning point | Full Text | References | PDF (1 MB) | EPUB
  • 339 Views
  • 0 CrossRef citations
  • 0Altmetric
Radiomics, mirnomics, and radiomirRNomics in glioblastoma: defining tumor biology from shadow to light
Ilaria Maggio, Enrico Franceschi, Lidia Gatto, Alicia Tosoni, Vincenzo Di Nunno, Caterina Tonon & Alba A. Brandes
Pages: 1265-1272
Published online: 30 Aug 2021
AbstractforRadiomics, mirnomics, and radiomirRNomics in glioblastoma: defining tumor biology from shadow to light | Full Text | References | PDF (310.5 KB) | EPUB
  • 197 Views
  • 3 CrossRef citations
  • 0Altmetric
Pathology and systemic therapy of non-clear cell renal cell carcinoma: an overview
Lothar Bergmann, Sarah Weber, Arndt Hartmann & Marit Ahrens
Pages: 1273-1286
Published online: 06 Aug 2021
AbstractforPathology and systemic therapy of non-clear cell renal cell carcinoma: an overview | Full Text | References | PDF (3 MB) | EPUB
  • 410 Views
  • 6 CrossRef citations
  • 0Altmetric

Original Research

Article
Low CBS expression can identify patients who benefit from adjuvant chemotherapy in gastric cancer
Jinsheng Zhao, Yusheng Zhao, Shasha Ding, Tao Liu & Fanzheng Meng
Pages: 1287-1298
Published online: 17 Aug 2021
AbstractforLow CBS expression can identify patients who benefit from adjuvant chemotherapy in gastric cancer | Full Text | References | PDF (5.8 MB) | EPUB | Supplemental
  • 244 Views
  • 1 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Immune-related adverse events associated with mogamulizumab: a comprehensive review of the literature
Genevieve S. Silva et al.
Review Article | Published online: 23 Jul 2024
Bevacizumab-containing treatment for relapsed or refractory Wilms tumor
Sarah Al-Jilaihawi et al.
Review Article | Published online: 23 Jul 2024
UNDERSTANDING the LINK BETWEEN ASPARTAME and CANCER
Morando Soffritti
Report | Published online: 23 Jul 2024
PROTACing the androgen receptor and other emerging therapeutics in prostate cancer
Peter D. Zang et al.
Review Article | Published online: 22 Jul 2024
View all latest articles